Industry Leaders’ Panel Discussion: Overcoming the Challenges of Toxicity, Extrahepatic Delivery & Scaling-Up in LNP Development to Accelerate a Wider Range of Therapeutics towards the Clinic
Time: 8:30 am
day: Day One
Details:
- What strategies are you implementing to enable greater cell specific delivery to targets outside of the liver?
- How does analytical development and manufacturing change for targeted LNPs to enable scale-up?
- What methods do you have in place to face the challenge of toxicity?